Camila Bragança Xavier (Camila B Xavier)

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 7

Top Topics

Tyrosine Kinase

Epidermal Growth Factor Receptor

Advanced Non Small Cell Lung Cancer

Top Venues

JCO precision oncology

Journal of gastrointestinal cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Nildevande F Lima, Luana A F Sampaio, Camila Bragança Xavier, Romulo L Mattedi, Marcelo A Queiroz, Willian C Nahas, Denis Leonardo Fontes Jardim
Complete Response to Sequential Human Epidermal Growth Factor Receptor 2-Targeted Strategies in a Heavily Pretreated Patient With Human Epidermal Growth Factor Receptor 2-Amplified Metastatic Bladder Cancer. JCO precision oncology 7 (2023)
Nildevande F Lima, Luana A F Sampaio, Camila Bragança Xavier, Romulo L Mattedi, Marcelo A Queiroz, Willian C Nahas, Denis Leonardo Fontes Jardim
Complete Response to Sequential Human Epidermal Growth Factor Receptor 2-Targeted Strategies in a Heavily Pretreated Patient With Human Epidermal Growth Factor Receptor 2-Amplified Metastatic Bladder Cancer. JCO precision oncology 7 (2023)
Nildevande F Lima, Luana A F Sampaio, Camila Bragança Xavier, Romulo L Mattedi, Marcelo A Queiroz, Willian C Nahas, Denis Leonardo Fontes Jardim
Complete Response to Sequential Human Epidermal Growth Factor Receptor 2-Targeted Strategies in a Heavily Pretreated Patient With Human Epidermal Growth Factor Receptor 2-Amplified Metastatic Bladder Cancer. JCO precision oncology 7 (2023)
Zenaide Silva de Souza, Camila Bragança Xavier, Luciana Beatriz Mendes Gomes, Maria Fernanda Barbosa de Medeiros, Micelange Carvalho de Sousa, Allan Andresson Lima Pereira, José Flávio Gomes Marin, Carlos Alberto Buchpiguel, Frederico Perego Costa
Survival and Response Outcomes for Gastrointestinal Neuroendocrine Tumor (GEP-NETs) Patients Treated with Lutetium-177-DOTATATE in a Brazilian Reference Center: A Six-Year Follow-Up Experience. Cancers 15 (18) (2023)
Camila Bragança Xavier, Rudinei Link, Leonília Abreu, Fabiana Bettoni, Fabiane Marson, Pedro A F Galante, Cibele Masotti, Mariane T Amano, Vinicius de Molla, Anamaria A Camargo, Paula F Asprino, Jorge Sabbaga
Suspected Germline TP53 Variants and Clonal Hematopoiesis of Indeterminate Potential: Lessons Learned From a Molecular Tumor Board. The oncologist (2023)
Camila Bragança Xavier, Carlos Diego H Lopes, Beatriz M Awni, Eduardo F Campos, João Pedro B Alves, Anamaria Aranha Camargo, Gabriela D A Guardia, Pedro Alexandre Favoretto Galante, Denis Leonardo Fontes Jardim
Interplay between Tumor Mutational Burden and Mutational Profile and Its Effect on Overall Survival: A Pilot Study of Metastatic Patients Treated with Immune Checkpoint Inhibitors. Cancers 14 (21) (2022)
Camila Bragança Xavier, Katia R Marchetti, Tiago B Castria, Denis L F Jardim, Gustavo S Fernandes
Trametinib and Hydroxychloroquine (HCQ) Combination Treatment in KRAS-Mutated Advanced Pancreatic Adenocarcinoma: Detailed Description of Two Cases. Journal of gastrointestinal cancer 52 (1) (2020)